Auriga Research provides comprehensive contract testing for pharmaceutical manufacturers, CROs, and API suppliers. From raw material identity to finished product release testing, our NABL-accredited and USFDA-registered laboratories deliver pharmacopeial-grade results on time.
Identity, assay, related substances, residual solvents, heavy metals, and water content per IP, BP, USP, and EP monographs.
Content uniformity, dissolution, disintegration, hardness, friability, and assay for tablets, capsules, injectables, and topicals.
ICH Q1A accelerated and long-term stability. Photostability per Q1B. Walk-in stability chambers with 24/7 monitoring and alarm systems.
Genotoxic impurities (ICH M7), elemental impurities (ICH Q3D), nitrosamine screening, and degradation product identification.
Reports accepted for ANDA, NDA, and CDSCO filings. No re-testing at the reviewer's end.
We test against IP, BP, USP, EP, and JP monographs. One lab for all your market requirements.
Express options available for urgent batch release. Real-time status tracking for every sample.
Share your product details and testing requirements. Our pharma team will provide a detailed quote within 24 hours.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing